Showing results (201-210 of 245) with videos related to
Sort By:
Pageof 25
The Lancet. Oncology|June 25, 2017
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 studyAlexander E Perl, Jessica K Altman, Jorge Cortes, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remissionSherif S Farag, Kati Maharry, Mei-Jie Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B studyKlaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.Blood|July 27, 2010
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studySusan P Whitman, Kati Maharry, Michael D Radmacher, et al.Blood Advances|January 15, 2026
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review & meta-analysisMaria Jose Oliveros, Saifur R Chowdhury, Yetiani Roldan, et al.Blood|April 25, 2012
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemiaAnn-Kathrin Eisfeld, Guido Marcucci, Kati Maharry, et al.Blood|March 11, 2025
Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaNatalie Wuliji, Salene M W Jones, Ted A Gooley, et al.Blood Advances|December 1, 2025
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adultsMikkael A Sekeres, Ryan J Mattison, Andrew S Artz, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDSH Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.Pageof 25